Literature DB >> 15818756

Severe chronic diarrhea and weight loss in cholesteryl ester storage disease: a case report.

Uta Drebber1, Matthias Andersen, Hans U Kasper, Peter Lohse, Manfred Stolte, Hans P Dienes.   

Abstract

AIM: An inherited deficiency of human lysosomal acid lipase (LAL) results in the rare conditions of Wolman disease and cholesteryl ester storage disease (CESD). We want to present the rare case of CESD in an adult.
METHODS: We report about an adult female patient with severe chronic diarrhea and weight loss as a consequence of CESD. Clinical examination revealed signs of malabsorption and slightly elevated liver enzymes.
RESULTS: Histopathologic changes in the liver tissue and DNA sequence analysis confirmed the diagnosis of CESD due to homozygosity for the most common CESD mutation, a G934A splice site defect encoded by exon 8 of the lysosomal acid lipase (LIPA) gene.
CONCLUSION: It is the first case in the literature with diarrhea as a putative symptom of CESD in adult patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15818756      PMCID: PMC4305829          DOI: 10.3748/wjg.v11.i15.2364

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  20 in total

1.  Cholesteryl ester storage disease: case report during childhood.

Authors:  Z Akçören; S Göğüş; N Koçak; F Gürakan; H Ozen; A Yüce
Journal:  Pediatr Dev Pathol       Date:  1999 Nov-Dec

2.  Liver transplantation for cholesteryl ester storage disease.

Authors:  G D Ferry; H H Whisennand; M J Finegold; E Alpert; A Glombicki
Journal:  J Pediatr Gastroenterol Nutr       Date:  1991-04       Impact factor: 2.839

3.  Compound heterozygosity for a Wolman mutation is frequent among patients with cholesteryl ester storage disease.

Authors:  P Lohse; S Maas; P Lohse; M Elleder; J M Kirk; G T Besley; D Seidel
Journal:  J Lipid Res       Date:  2000-01       Impact factor: 5.922

4.  Subclinical course of cholesteryl ester storage disease in an adult with hypercholesterolemia, accelerated atherosclerosis, and liver cancer.

Authors:  M Elleder; A Chlumská; J Hyánek; H Poupĕtová; J Ledvinová; S Maas; P Lohse
Journal:  J Hepatol       Date:  2000-03       Impact factor: 25.083

5.  Cholesteryl ester storage disease: a patient with massive splenomegaly and splenic abscess.

Authors:  R A Edelstein; M R Filling-Katz; P Pentchev; A Gal; R Chandra; T Shawker; P Guzzetta; M Comly; C Kaneski; R O Brady
Journal:  Am J Gastroenterol       Date:  1988-06       Impact factor: 10.864

6.  Homozygosity for a splice junction mutation in exon 8 of the gene encoding lysosomal acid lipase in a Spanish kindred with cholesterol ester storage disease (CESD).

Authors:  S Muntoni; H Wiebusch; H Funke; E Ros; U Seedorf; G Assmann
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

7.  New lysosomal acid lipase gene mutants explain the phenotype of Wolman disease and cholesteryl ester storage disease.

Authors:  F Pagani; R Pariyarath; R Garcia; C Stuani; A B Burlina; G Ruotolo; M Rabusin; F E Baralle
Journal:  J Lipid Res       Date:  1998-07       Impact factor: 5.922

8.  A splice junction mutation causes deletion of a 72-base exon from the mRNA for lysosomal acid lipase in a patient with cholesteryl ester storage disease.

Authors:  H Klima; K Ullrich; C Aslanidis; P Fehringer; K J Lackner; G Schmitz
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

9.  Molecular defects underlying Wolman disease appear to be more heterogeneous than those resulting in cholesteryl ester storage disease.

Authors:  P Lohse; S Maas; A C Sewell; D Seidel
Journal:  J Lipid Res       Date:  1999-02       Impact factor: 5.922

10.  Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity.

Authors:  C Aslanidis; S Ries; P Fehringer; C Büchler; H Klima; G Schmitz
Journal:  Genomics       Date:  1996-04-01       Impact factor: 5.736

View more
  7 in total

Review 1.  Cholesterol ester storage disease (CESD) diagnosed in an asymptomatic adult.

Authors:  Hemant Chatrath; Steven Keilin; Bashar M Attar
Journal:  Dig Dis Sci       Date:  2008-05-14       Impact factor: 3.199

2.  Hepatic entrapment of esterified cholesterol drives continual expansion of whole body sterol pool in lysosomal acid lipase-deficient mice.

Authors:  Amal Aqul; Adam M Lopez; Kenneth S Posey; Anna M Taylor; Joyce J Repa; Dennis K Burns; Stephen D Turley
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-08-21       Impact factor: 4.052

Review 3.  [Lysosomal acid lipase deficiency (LAL-D) : Diagnostic and therapeutic options in an underdiagnosed disease].

Authors:  S Synoracki; S Kathemann; K W Schmid; H Jastrow; H A Baba
Journal:  Pathologe       Date:  2018-05       Impact factor: 1.011

4.  Frequency of the cholesteryl ester storage disease common LIPA E8SJM mutation (c.894G>A) in various racial and ethnic groups.

Authors:  Stuart A Scott; Benny Liu; Irina Nazarenko; Suparna Martis; Julia Kozlitina; Yao Yang; Charina Ramirez; Yumi Kasai; Tommy Hyatt; Inga Peter; Robert J Desnick
Journal:  Hepatology       Date:  2013-07-29       Impact factor: 17.425

5.  A case of abdominal pain with dyslipidemia: difficulties diagnosing cholesterol ester storage disease.

Authors:  S J Cameron; U Daimee; R C Block
Journal:  Eur Rev Med Pharmacol Sci       Date:  2015       Impact factor: 3.507

Review 6.  Targeting Wolman Disease and Cholesteryl Ester Storage Disease: Disease Pathogenesis and Therapeutic Development.

Authors:  Francis Aguisanda; Natasha Thorne; Wei Zheng
Journal:  Curr Chem Genom Transl Med       Date:  2017-01-30

7.  Lysosomal Acid Lipase Deficiency, a Rare Pathology: The First Pediatric Patient Reported in Colombia.

Authors:  Verónica Botero; Victor H Garcia; Catalina Gomez-Duarte; Ana M Aristizabal; Ana M Arrunategui; Gabriel J Echeverri; Harry Pachajoa
Journal:  Am J Case Rep       Date:  2018-06-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.